Proprietary Pipeline

Candidate
& Indication
LEAD CANDIDATE:
TRIOZAN/siRNA Gal-1 (checkpoint inhibitor combination regimen)
► Cancer (Head & Neck)
Discovery
Research
Candidate
Optimization
Preclinical Clinical

Collaborations

Program Partner
TRIOZAN™/mAb
► Central Nervous System
Program Partner
TRIOZAN™/Cannabinoids
► Glioblastoma Multiforme
Discovery
Research
Candidate
Optimization
Discovery
Research
Candidate
Optimization

Proprietary Pipeline

Candidate
& Indication
LEAD CANDIDATE:
TRIOZAN/siRNA Gal-1
(checkpoint inhibitor
combination regimen)
► Cancer (Head & Neck)
Candidate Optimization

Collaborations

Program
TRIOZAN™/mAb
► Central Nervous
System
Partner:
Discovery Research
Program
TRIOZAN™/Cannabinoids
► Glioblastoma
Multiforme
Partner:
Discovery Research